Table 1.
Patient and procedural characteristics.
| U group (61 patients, 65 procedures) | C group (76 patients, 79 procedures) | P value | |
|---|---|---|---|
| Age, years | 70.4 ± 10.5 | 74.1 ± 9.6 | 0.03 |
| Male, % | 42 (69) | 53 (70) | 0.91 |
| Height, cm | 161.4 ± 10.4 | 162.1 ± 9.0 | 0.67 |
| Weight, kg | 64.6 ± 16.1 | 62.0 ± 11.3 | 0.27 |
| BMI, kg/m2 | 25.0 ± 4.0 | 23.8 ± 3.5 | 0.08 |
| Smoking, % | 14 (23) | 19 (25) | 0.86 |
| Hypertension, % | 48 (79) | 60 (79) | 0.97 |
| Diabetes mellitus, % | 30 (49) | 29 (38) | 0.20 |
| Dyslipidemia, % | 45 (74) | 52 (68) | 0.49 |
| eGFR, ml/min/1.73 m2 | 62.8 ± 26.6 | 60.9 ± 21.6 | 0.65 |
| CKD, % | 22 (36) | 29 (38) | 0.80 |
| Hemodialysis, % | 6 (10) | 4 (5) | 0.31 |
| PAD, % | 5 (8) | 4 (5) | 0.49 |
| CVD, % | 4 (7) | 4 (5) | 0.75 |
| Prior MI, % | 6 (10) | 6 (8) | 0.69 |
| Aspirin, % | 53 (87) | 62 (82) | 0.40 |
| Thienopyridine, % | 42 (69) | 55 (72) | 0.65 |
| Anticoagulant, % | 5 (8) | 7 (9) | 0.83 |
| Left hand, % | 17 (27) | 23 (29) | 0.60 |
| Sheath size | |||
| 4 Fr, % | 0 | 2 (3) | 0.32 |
| 5 Fr, % | 57 (88) | 64 (81) | |
| 6 Fr, % | 8 (12) | 13 (16) | |
| CAG, % | 45 (69) | 55 (70) | 0.96 |
| PCI, % | 20 (31) | 24 (30) |
BMI, body mass index; CKD, chronic kidney disease; PAD, peripheral artery disease; CVD, cerebral vascular disease; MI, myocardial infarction; CAG, coronary angiography; PCI, percutaneous coronary intervention; eGFR, estimated glomerular filtration rate.